Drug Approval | October 09, 2021
Gland Pharma receives tentative nod for Sugammadex injection
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
The platform will provide a safe and nurturing space for women, and non-binary individuals
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
This product will be manufactured at Lupin’s Pithampur facility In India
The transaction is anticipated to close in the first quarter of 2022
The initiative will create an integrated network of Critical Care Units (CCUs) across the Apollo Hospitals network but also in partnership with non-Apollo units in India and overseas
Subscribe To Our Newsletter & Stay Updated
